Pectasides, Dimitrios
Henry Dunant Hospital,
Greece
2025 Rank: 173014
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 6372 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 173014 | 191195 |
| Total Cites | 9530 | 10633 |
| H-index | 52 | 56 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 95 | 95 |
| Total Cites to Single+First Authored Papers | 3195 | 3300 |
| Number of Single+First+Last Authored Papers | 127 | 127 |
| Total Cites to Single+First+Last Authored Papers | 3912 | 4046 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8973 | 9620 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.11 |
| Self-Citation Percentage |
10.37%
|
|
Pectasides, Dimitrios
Hippokration General Hospital,
Greece
2024 Rank: 163810
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 6124 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 163810 | 182676 |
| Total Cites | 9097 | 10172 |
| H-index | 51 | 54 |
| Hm-index | 18 | 18 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 95 | 95 |
| Total Cites to Single+First Authored Papers | 3098 | 3201 |
| Number of Single+First+Last Authored Papers | 127 | 127 |
| Total Cites to Single+First+Last Authored Papers | 3781 | 3909 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8549 | 9179 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.11 |
| Self-Citation Percentage |
10.57%
|
|
Pectasides, Dimitrios
Hippokration General Hospital,
Greece
2023 Rank: 159453
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 6030 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 159453 | 174250 |
| Total Cites | 8586 | 9647 |
| H-index | 49 | 53 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 95 | 95 |
| Total Cites to Single+First Authored Papers | 2965 | 3068 |
| Number of Single+First+Last Authored Papers | 127 | 127 |
| Total Cites to Single+First+Last Authored Papers | 3608 | 3735 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8060 | 8677 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.11 |
| Self-Citation Percentage |
11.00%
|
|
Pectasides, Dimitrios
Hippokration General Hospital,
Greece
2022 Rank: 150737
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Gastroenterology & Hepatology
Rank in SubField 1: 5712 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 150737 | 167111 |
| Total Cites | 8001 | 9024 |
| H-index | 47 | 50 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 95 | 95 |
| Total Cites to Single+First Authored Papers | 2835 | 2937 |
| Number of Single+First+Last Authored Papers | 127 | 127 |
| Total Cites to Single+First+Last Authored Papers | 3420 | 3545 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7504 | 8104 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.11 |
| Self-Citation Percentage |
11.34%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.